Vaccinex Inc. (VCNX)

Business: Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs.

IPO Date: 09-Aug-2018

Co-Founder, CEO, Pres & Director: Dr. Maurice Zauderer Ph.D.

Chief Financial Officer: Mr. Scott E. Royer C.F.A., M.B.A.

Listing: NASDAQ: VCNX

Country: United States

Headquarters: Rochester, NY

Website: https://www.vaccinex.com

Market cap: $46.50 Mln

Revenue (TTM): $0.90 Mln

Earnings (TTM): $-20.40 Mln

Cash: $16.80 Mln

Total Debt: $0.33 Mln

Insider's Holding: 12.06%

Liquidity: Low

52 Week range: $0.90 - 2.91

Shares outstanding: 42,664,100

6 Years Aggregate:

• CFO: $-151.04 Mln
• EBITDA: $-147.21 Mln
• Net Profit: $-145.28 Mln